REFERENCES
- Castle D, Daniel J, Knott J, Fielding J, Goh J, Singh B. Developments of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychoses. Australasian Psychiatry 2005; 13: 247–252.
- Allen MH, Currier GW, Hughes DH, Reyes-Hardie M, Docherty TP, Ross RW. Treatment of behavioural emergencies. Post Graduate Medicine Special Report 2001; May: 1–88.
- Currier GW, Chou JC-Y, Feifel D. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. Journal of Clinical Psychiatry 2004; 65: 386–394.
- Breier A, Meehan K, Birkett M. A double blind placebo-controlled comparison at intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Archives of General Psychiatry 2002; 59: 441–448.
- Bazire S. Acute Psychiatric Emergency including Rapid Tranquillisation. : , 2010; 14.
- Emmerson B, Fawcett L, Ward W, Catts S, Ng A, Frost A. Contemporay manangement of aggression in an inner-city mental health service. Australasian Psychiatry 2007; 15: 115–119.
- Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP; Expert Consensus Panel for Behavioural Emergencies. The expert consensus guideline series. Treatment of behavioural emergencies 2005. Journal of Psychiatry Practice 2005; 11: S5–108.
- Stahl SM. Lorazepam. In: SM Stahl, Essential Psychopharmacology: Prescribers Guide, 3rd. Cambridge: Cambridge University Press, 2009; 298.
- Lambert M, Huber CG, Naber D . Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizaffective, or bipolar 1 disorder. Pharmacopsychiatry 2008; 41: 182–189.